Direct analysis of psychoactive tryptamine and harmala alkaloids in the Amazonian botanical medicine ayahuasca by liquid chromatography-electrospray ionization-tandem mass spectrometry.
Ethan H. Mcilhenny, Kelly E Pipkin, Leanna J Standish, Hope A Wechkin, Rick J. Strassman, Steven A. Barker
Journal of Chromatography A December 18, 2009 DOI: 10.1016/j.chroma.2009.10.088 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Method development and validation Peer reviewed |
|---|---|
| Population | Ayahuasca preparations |
| Topics | Ayahuasca |
| Keywords | Analytical chemistry Mass spectrometry Psychoactive compounds |
| Citations | 58 |
| Key points | A rapid, specific, and sensitive direct injection/liquid chromatography-tandem mass spectrometry method was developed for simultaneous quantitation of 11 alkaloids in ayahuasca, requiring only sample dilution and no extraction. |
Abstract
A direct injection/liquid chromatography-electrospray ionization-tandem mass spectrometry procedure has been developed for the simultaneous quantitation of 11 compounds potentially found in the increasingly popular Amazonian botanical medicine and religious sacrament ayahuasca. The method utilizes a deuterated internal standard for quantitation and affords rapid detection of the alkaloids by a simple dilution assay, requiring no extraction procedures. Further, the method demonstrates a high degree of specificity for the compounds in question, as well as low limits of detection and quantitation despite using samples for analysis that had been diluted up to 200:1. This approach also appears to eliminate potential matrix effects. Method bias for each compound, examined over a range of concentrations, was also determined as was inter- and intra-assay variation. Its application to the analysis of three different ayahuasca preparations is also described. This method should prove useful in the study of ayahuasca in clinical and ethnobotanical research as well as in forensic examinations of ayahuasca preparations.
Citations in the library
Cited by 33
- Exploring the therapeutic potential of Ayahuasca: acute intake increases mindfulness-related capacities Psychopharmacology November 27, 2015
- Assessing the Psychedelic “After-Glow” in Ayahuasca Users: Post-Acute Neurometabolic and Functional Connectivity Changes Are Associated with Enhanced Mindfulness Capacities The International Journal of Neuropsychopharmacology May 17, 2017
- Ayahuasca enhances creative divergent thinking while decreasing conventional convergent thinking Psychopharmacology July 19, 2016
- Ayahuasca: Psychological and Physiologic Effects, Pharmacology and Potential Uses in Addiction and Mental Illness Current Neuropharmacology March 2, 2018
- Inhibition of alpha oscillations through serotonin-2A receptor activation underlies the visual effects of ayahuasca in humans European Neuropsychopharmacology March 26, 2016
and 28 more in the library
Cites 13
- Monoamine oxidase inhibitors in South American hallucinogenic plants: Tryptamine and β-carboline constituents of Ayahuasca Journal of Ethnopharmacology April 1, 1984
- Human Pharmacology of Ayahuasca: Subjective and Cardiovascular Effects, Monoamine Metabolite Excretion, and Pharmacokinetics Journal of Pharmacology and Experimental Therapeutics June 18, 2003
- Clinical investigations of the therapeutic potential of ayahuasca: rationale and regulatory challenges. Pharmacology & Therapeutics May 1, 2004
- Risk assessment of ritual use of oral dimethyltryptamine (DMT) and harmala alkaloids Addiction December 20, 2006
- Effects of ayahuasca on psychometric measures of anxiety, panic-like and hopelessness in Santo Daime members Journal of Ethnopharmacology April 26, 2007
and 8 more in the library